Investing Profile

Sara Secall

InvestorVC
Operating Partner at Inveready Technology Investment Group
inveready.com/team/Barcelona, Spain
Photo of Sara Secall, Partner at Inveready Technology Investment Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$300K - $1.8M
$875K
5
CompanyStageDateRound SizeTotal Raised
Ability Pharmaceuticals
Series UnknownMar 2024$8M
$8M
Innerva Pharmaceuticals
SeedOct 2022$2M
$2M
AptaTargets
Series BOct 2020$6M
Series UnknownMay 2017$3M
$9M
Spiral Therapeutics
Series ADec 2018$6M
$6M
Co-investors: George C. Petrocheilos (Catalio Capital)